Back to search

Optimizing vaccine design for cellular processing, MHC binding and TCR recognition

Data up to Jan 2025

Published2002
Citations105
References47

Total Citations Per Year

Abstract

References (47)

IMMUNODOMINANCE IN MAJOR HISTOCOMPATIBILITY COMPLEX CLASS I–RESTRICTED T LYMPHOCYTE RESPONSES

1999 • 923 citations

The relationship between class I binding affinity and immunogenicity of potential cytotoxic T cell epitopes.

1994 • 838 citations

Several Common HLA-DR Types Share Largely Overlapping Peptide Binding Repertoires

1998 • 647 citations

Prominent role of secondary anchor residues in peptide binding to HLA-A2.1 molecules

1993 • 630 citations

Nine major HLA class I supertypes account for the vast preponderance of HLA-A and -B polymorphism

1999 • 619 citations

Improved induction of melanoma-reactive CTL with peptides from the melanoma antigen gp100 modified at HLA-A*0201-binding residues.

1996 • 566 citations

Enhanced Antigen-Specific Antitumor Immunity with Altered Peptide Ligands that Stabilize the MHC-Peptide-TCR Complex

2000 • 312 citations

Prediction of major histocompatibility complex binding regions of protein antigens by sequence pattern analysis.

1989 • 310 citations

A Rational Strategy to Design Multiepitope Immunogens Based on Multiple Th Lymphocyte Epitopes

2002 • 298 citations

Definition of specific peptide motifs for four major HLA-A alleles.

1994 • 282 citations

Practical, biochemical and evolutionary implications of the discovery of HLA class I supermotifs

1996 • 263 citations

Two complementary methods for predicting peptides binding major histocompatibility complex molecules

1997 • 261 citations

Melanoma-specific CD4+ T cells recognize nonmutated HLA-DR-restricted tyrosinase epitopes.

1996 • 259 citations

HLA supertypes and supermotifs: a functional perspective on HLA polymorphism

1998 • 244 citations

Peptide binding to the most frequent HLA-A class I alleles measured by quantitative molecular binding assays

1994 • 233 citations

Identification of an enhancer agonist cytotoxic T lymphocyte peptide from human carcinoembryonic antigen.

1997 • 210 citations

Utilization of MHC Class I Transgenic Mice for Development of Minigene DNA Vaccines Encoding Multiple HLA-Restricted CTL Epitopes

1999 • 166 citations

Identification of Db- and Kb-Restricted Subdominant Cytotoxic T-Cell Responses in Lymphocytic Choriomeningitis Virus-Infected Mice

1998 • 164 citations

Structure‐based prediction of binding peptides to MHC class I molecules: Application to a broad range of MHC alleles

2000 • 155 citations

Optimization of epitope processing enhances immunogenicity of multiepitope DNA vaccines

2001 • 155 citations

Structural Features of Peptide Analogs of Human Histocompatibility Leukocyte Antigen Class I Epitopes That Are More Potent and Immunogenic than Wild-Type Peptide

2001 • 147 citations

DNA multi-CTL epitope vaccines for HIV and Plasmodium falciparum: immunogenicity in mice

1998 • 140 citations

Identification of New Epitopes from Four Different Tumor-Associated Antigens: Recognition of Naturally Processed Epitopes Correlates with HLA-A∗0201-Binding Affinity

2001 • 136 citations

Characterization of the specificity of peptide binding to four DR haplotypes.

1990 • 134 citations

Majority of peptides binding HLA-A∗0201 with high affinity crossreact with other A2-supertype molecules

2001 • 123 citations

Differences and similarities in the A2.1‐restricted cytotoxic T cell repertoire in humans and human leukocyte antigen‐transgenic mice

1996 • 119 citations

Identification and Antigenicity of Broadly Cross-Reactive and Conserved Human Immunodeficiency Virus Type 1-Derived Helper T-Lymphocyte Epitopes

2001 • 108 citations

Effective induction of HIV-specific CTL by multi-epitope using gene gun in a combined vaccination regime

1999 • 106 citations

The Development of Multi-epitope Vaccines: Epitope Identification, Vaccine Design and Clinical Evaluation

2001 • 103 citations

Effect of pH on MHC class II-peptide interactions.

1992 • 101 citations

A multivalent minigene vaccine, containing B-cell, cytotoxic T-lymphocyte, and Th epitopes from several microbes, induces appropriate responses in vivo and confers protection against more than one pathogen

1997 • 90 citations

Peptide binding to MHC class I molecules: Implications for antigenic peptide prediction

1995 • 81 citations

Immunodominance: intramolecular competition between T cell epitopes.

1991 • 77 citations

Derivation of HLA-A11/Kb transgenic mice: functional CTL repertoire and recognition of human A11-restricted CTL epitopes.

1997 • 73 citations

Identification of the Peptide Binding Motif for HLA-B44, One of the Most Common HLA-B Alleles in the Caucasian Population

1995 • 73 citations

Peptides derived from self-proteins as partial agonists and antagonists of human CD8+ T-cell clones reactive to melanoma/melanocyte epitope MART1(27-35).

1998 • 71 citations

Assessment of Immunogenicity of Human Melan-A Peptide Analogues in HLA-A*0201/Kb Transgenic Mice

1999 • 65 citations

Sequence signals for generation of antigenic peptides by the proteasome: implications for proteasomal cleavage mechanism

2000 • 59 citations

Uncovering subdominant cytotoxic T-lymphocyte responses in lymphocytic choriomeningitis virus-infected BALB/c mice

1997 • 58 citations

Definition of the Mamu A*01 Peptide Binding Specificity: Application to the Identification of Wild-Type and Optimized Ligands from Simian Immunodeficiency Virus Regulatory Proteins

2000 • 53 citations

A disease-related epitope of Torpedo acetylcholine receptor. Residues involved in I-Ab binding, self-nonself discrimination, and TCR antagonism.

1994 • 47 citations

The Stimulation of Low-Affinity, Nontolerized Clones by Heteroclitic Antigen Analogues Causes the Breaking of Tolerance Established to an Immunodominant T Cell Epitope

1999 • 42 citations

Identification of Five Different Patr Class I Molecules That Bind HLA Supertype Peptides and Definition of Their Peptide Binding Motifs

2000 • 28 citations

HLA transgenic mice as models of human autoimmune diseases.

2000 • 25 citations

Silencing of immunodominant epitopes by contiguous sequences in complex synthetic peptides

1992 • 20 citations

Epitope identification and vaccine design for cancer immunotherapy.

2002 • 20 citations

HLA-binding peptides as a therapeutic approach for chronic HIV infection.

2000 • 6 citations

Cited By (0)

Loading...
Optimizing vaccine design for cellular processing, MHC binding and TCR recognition (2002) – Tissue Antigens | Metascience Observatory Explorer